Can my ropinirole (Requip) dose be increased from 2 mg?

Should Your Ropinirole Dose Be Increased from 2 mg?

I recommend against routinely increasing your ropinirole dose, and instead suggest discussing alternative treatments with your physician, particularly if you're taking this for restless legs syndrome (RLS). The most recent 2025 American Academy of Sleep Medicine guidelines now recommend against the standard use of ropinirole for RLS due to significant long-term risks, particularly augmentation (worsening of symptoms) 1.

Critical Context: Why This Matters

The 2025 AASM guidelines represent a major shift in RLS treatment recommendations. The guidelines suggest against the standard use of ropinirole (conditional recommendation, moderate certainty of evidence) 1. While ropinirole can reduce RLS symptoms in the short term, the long-term risks—especially augmentation where your symptoms actually worsen and spread—make it problematic for ongoing use.

What You Should Know About Augmentation

Augmentation is a phenomenon where:

• Your RLS symptoms start earlier in the day
• Symptoms become more severe
• Symptoms spread to other body parts (arms, trunk)
• You need progressively higher doses to control symptoms
• This creates a vicious cycle

Increasing your dose may provide temporary relief but increases your risk of augmentation, which could leave you worse off than when you started 1.

If You're Taking This for RLS

Preferred Alternatives (per 2025 Guidelines):

1. Check your iron status first - The AASM suggests ferrous sulfate if your ferritin and transferrin saturation are appropriate 1

2. Consider these options instead:

   • Dipyridamole (conditional recommendation) 1
   • Extended-release oxycodone or other opioids (conditional recommendation, moderate certainty) 1
   • Bilateral high-frequency peroneal nerve stimulation 1

3. If you have kidney disease (ESRD):

   • Gabapentin is suggested 1
   • IV iron sucrose if ferritin <200 ng/mL and transferrin saturation <20% 1

When Ropinirole Might Still Be Used

The guidelines acknowledge ropinirole may be appropriate only if you:

• Place higher value on short-term symptom reduction
• Place lower value on long-term adverse effects
• Understand and accept the augmentation risk 1

If You're Taking This for Parkinson's Disease

The situation is different for Parkinson's disease, where ropinirole remains an established treatment option:

Dosing Considerations:

• Most patients respond at ≤7.5 mg/day 2
• The FDA-approved maximum is 24 mg/day 3
• Some studies show benefit with continued titration up to 14-15 mg/day over years 2
• High-dose therapy (20-36 mg/day) has been studied and showed benefit in advanced disease with motor fluctuations 4

If you're on 2 mg for Parkinson's disease and still symptomatic, dose escalation is reasonable - 75% of therapeutic responders achieve benefit at ≤7.5 mg/day, so there's room for careful upward titration 2.

Important Safety Considerations

Drug Interactions to Watch:

• Ciprofloxacin increases ropinirole levels by 84% - avoid this combination or reduce ropinirole dose 3
• Estrogens reduce ropinirole clearance by 36% - you may need lower doses if taking estrogen 3
• Smoking reduces ropinirole levels by 30-38% - smokers may need higher doses 3

Renal Impairment:

• Moderate impairment (CrCl 30-50 mL/min): no adjustment needed 3
• End-stage renal disease on hemodialysis: maximum dose is lower - clearance reduced by 30% 3

Common Pitfalls to Avoid

1. Don't chase symptoms with dose increases in RLS - this accelerates augmentation
2. Don't ignore iron status - correcting iron deficiency may eliminate the need for dopamine agonists entirely
3. Don't continue ropinirole long-term for RLS without considering alternatives - the 2025 guidelines reflect growing evidence against this practice

Bottom Line Algorithm

For RLS:

1. Check ferritin and transferrin saturation
2. Correct iron deficiency if present
3. Consider switching to preferred alternatives (dipyridamole, opioids, nerve stimulation)
4. If staying on ropinirole, use lowest effective dose and monitor closely for augmentation

For Parkinson's Disease:

1. If symptomatic on 2 mg, gradual titration upward is appropriate
2. Target 7.5 mg/day initially (where most responses occur)
3. Can titrate higher if needed and tolerated
4. Monitor for dyskinesia, hallucinations, and impulse control disorders

The decision hinges entirely on your indication for treatment. Discuss with your physician whether continuing ropinirole—let alone increasing it—remains the best strategy for your specific condition.